ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...

ICON plc’s ICLR focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added plus. The stock carries a Zacks Rank #2 (Buy) ...

CEO Steve Cutler introduced Barry Balfe as the newly appointed COO, highlighting his 20-year tenure at ICON and focus on strengthening strategic partnerships across the mid-size customer segment. The ...

On Thursday, 13 March 2025, ICON PLC (NASDAQ: ICLR) participated in the Barclays 27th Annual Global Healthcare Conference. The company shared insights into its strategic challenges and opportunities.

DUBLIN--(EON: Enhanced Online News)--ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device ...

With emphasis on “placing the patient at the center of all that we do,” Walter Reed Bethesda (WRB) Director Brig. Gen. Jeffrey B. Clark introduced a draft of the medical center’s new strategic plan ...